Loading…
Abstract P1-18-03: Phase I trial to assess the safety, pharmacokinetics and pharmacodynamics of receptor activator of nuclear factor-κB ligand inhibitor (TK006) in patients with bone metastases from breast cancer
Mei, YY, Hai, TJ, Wei, L, Xiang, H, Hao, W, Ming, ZX, An, LX
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Loading…
Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy
Todenhöfer, Tilman, Hennenlotter, Jörg, Leidenberger, Philipp, Wald, Alexander, Hohneder, Andrea, Kühs, Ursula, Mischinger, Johannes, Aufderklamm, Stefan, Gakis, Georgios, Blumenstock, Gunnar, Stenzl, Arnulf, Schwentner, Christian
Published in BJU international (01.01.2014)
Published in BJU international (01.01.2014)
Get full text
Journal Article
Loading…
Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Cardiovascular Disease
Kiechl, Stefan, Schett, Georg, Schwaiger, Judith, Seppi, Klaus, Eder, Paula, Egger, Georg, Santer, Peter, Mayr, Agnes, Xu, Qingbo, Willeit, Johann
Published in Circulation (New York, N.Y.) (24.07.2007)
Published in Circulation (New York, N.Y.) (24.07.2007)
Get full text
Journal Article
Loading…
Loading…
Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases
Bostancı, N., İlgenli, T., Emingil, G., Afacan, B., Han, B., Töz, H., Berdeli, A., Atilla, G., McKay, I. J., Hughes, F. J., Belibasakis, G. N.
Published in Journal of periodontal research (01.08.2007)
Published in Journal of periodontal research (01.08.2007)
Get full text
Journal Article
Loading…
Receptor activator of nuclear factor κB ligand is a biomarker for osteitis of chronic rhinosinusitis
Kong, Il Gyu, Kim, Dong‐Kyu, Eun, Kyoung Mi, Yang, Seung Koo, Kim, Minju, Oh, Heonjeong, Kim, Dae Woo
Published in International forum of allergy & rhinology (01.03.2020)
Published in International forum of allergy & rhinology (01.03.2020)
Get full text
Journal Article
Loading…
Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
Alexandrou, Andreas, Creatsa, Maria, Karavanaki, Kyriaki, Lambrinoudaki, Irene, Pliatsika, Paraskevi, Augoulea, Areti, Stamatelopoulos, Kimon, Tsouvalas, Emmanouil, Vakaki, Marina, Kaparos, George
Published in International journal of endocrinology (01.01.2013)
Published in International journal of endocrinology (01.01.2013)
Get full text
Journal Article
Loading…
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease
Ugay, Ludmila, Kochetkova, Evgenia, Nevzorova, Vera, Maistrovskaia, Yuliya
Published in Chinese medical journal (20.07.2016)
Published in Chinese medical journal (20.07.2016)
Get full text
Journal Article
Loading…
Constitutive expression of cathepsin K in the human intervertebral disc: new insight into disc extracellular matrix remodeling via cathepsin K and receptor activator of nuclear factor-κB ligand
Gruber, Helen E, Ingram, Jane A, Hoelscher, Gretchen L, Zinchenko, Natalia, Norton, H James, Hanley, Edward N
Published in Arthritis research & therapy (31.08.2011)
Published in Arthritis research & therapy (31.08.2011)
Get full text
Journal Article
Loading…
Elevated soluble receptor activator of nuclear factor-κB ligand and reduced bone mineral density in patients with adolescent idiopathic scoliosis
Suh, Kuen Tak, Lee, Sang-Sup, Hwang, Sang Hyun, Kim, Seong-Jang, Lee, Jung Sub
Published in European spine journal (01.10.2007)
Published in European spine journal (01.10.2007)
Get full text
Journal Article
Loading…
Loading…
Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in post-menopausal women
Uemura, H., Yasui, T., Miyatani, Y., Yamada, M., Hiyoshi, M., Arisawa, K., Irahara, M.
Published in Journal of endocrinological investigation (01.02.2008)
Published in Journal of endocrinological investigation (01.02.2008)
Get full text
Journal Article
Loading…
Serum osteoprotegerin and soluble receptor activator of nuclear factor κB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study
Giusti, Massimo, Cecoli, Francesca, Fazzuoli, Laura, De Franchis, Vincenzina, Ceresola, Enrica, Ferone, Diego, Mussap, Michele, Minuto, Francesco
Published in Metabolism, clinical and experimental (01.05.2007)
Published in Metabolism, clinical and experimental (01.05.2007)
Get full text
Journal Article
Loading…
The relationship between Receptor Activator of Nuclear Factor-κB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women
Rhee, Eun-Jung, Yun, Eun-Joo, Oh, Ki-Won, Park, Se Eun, Park, Cheol-Young, Lee, Won-Young, Park, Sung-Woo, Kim, Sun-Woo, Baek, Ki-Hyun, Kang, Moo Il
Published in Endocrine Journal (2010)
Published in Endocrine Journal (2010)
Get full text
Journal Article
Loading…
Circulating levels of receptor activator of nuclear factor-κb ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population
TROFIMOV, Svetlana, PANTSULAIA, Ia, KOBYLIANSKY, Eugene, LIVSHITS, Gregory
Published in European journal of endocrinology (01.03.2004)
Published in European journal of endocrinology (01.03.2004)
Get full text
Journal Article
Loading…
A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study
Yoshida, T., Kinoshita, H., Taniguchi, H., Yanishi, M., Sugi, M., Matsuda, T.
Published in Osteoporosis international (01.07.2020)
Published in Osteoporosis international (01.07.2020)
Get full text
Journal Article
Loading…
Soluble Receptor Activator of Nuclear Factor-κB Ligand (sRANKL)/Osteoprotegerin Balance in Ageing and Age-Associated Diseases
Pulsatelli, Lia, Dolzani, Paolo, Silvestri, Tania, Caraceni, Paolo, Facchini, Andrea, Ravaglia, Giovanni, Salvarani, Carlo, Melicòni, Riccardo, Mariani, Erminia
Published in Biogerontology (Dordrecht) (01.01.2004)
Published in Biogerontology (Dordrecht) (01.01.2004)
Get full text
Journal Article
Loading…
The relationship between Receptor Activator of Nuclear Factor-κB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women
Eun-Jung Rhee, Eun-Joo Yun, Ki-Won Oh, Se Eun Park, Cheol-Young Park, Won-Young Lee, Sung-Woo Park, Sun-Woo Kim, Ki-Hyun Baek, Moo Il Kang
Published in ENDOCRINE JOURNAL (2010)
Get full text
Published in ENDOCRINE JOURNAL (2010)
Journal Article
Loading…
Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction
Crisafulli, Alessandra, Micari, Antonio, Altavilla, Domenica, Saporito, Francesco, Sardella, Aurora, Passaniti, Maria, Raffa, Santi, D'Anneo, Gaspare, Lucà, Fabiana, Mioni, Chiara, Arrigo, Francesco, Squadrito, Francesco
Published in Clinical science (1979) (01.10.2005)
Published in Clinical science (1979) (01.10.2005)
Get full text
Journal Article
Loading…
Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints
Smith, M D, Barg, E, Weedon, H, Papengelis, V, Smeets, T, Tak, P P, Kraan, M, Coleman, M, Ahern, M J
Published in Annals of the rheumatic diseases (01.04.2003)
Published in Annals of the rheumatic diseases (01.04.2003)
Get full text
Journal Article